Finding 400364 (2023-003)

Material Weakness
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2024-06-07
Audit: 308411
Organization: Optimus Health Care, Inc. (CT)
Auditor: Whittlesey PC

AI Summary

  • Core Issue: The Organization lacks proper documentation for its cost allocation plan, leading to unsupported cost allocations for federal awards.
  • Impacted Requirements: Compliance with Title 2 U.S. Code of Federal Regulations Part 200, which mandates reasonable and documented cost allocation methodologies.
  • Recommended Follow-up: Document the basis for cost allocations, retain supporting documentation, and regularly update the cost allocation plan with Board approval.

Finding Text

Finding No. 2023-003: Activities Allowed or Unallowed and Allowable Costs/Cost Principles – Material Weakness Federal Program Name: All Pass-through Entity: All Federal Assistance Listing Number: All Criteria Title 2 U.S. Code of Federal Regulations Part 200 establishes cost principles for determining costs applicable to federal awards. These principles include the requirement that cost allocation methodologies be reasonable and documented and that all expenses charged to federal awards are appropriately supported. The cost allocations should be reviewed and updated for changes to operations. Condition The Organization was unable to produce documentation supporting its cost allocation plan (“CAP”). Operating expenditures reported on submitted grant reports did not consistently reconcile directly back to the underlying accounting records. Cause The Organization was unable to produce support for the allocation of costs to federal awards. The CAP has not been updated regularly. Effect The basis for computing and allocating costs to federal awards according to the CAP is unsupported. Questioned Costs Unknown. Context The Organization is unable to document the basis for allocating costs to its federal awards. Recommendation We recommend that the Organization document its basis for allocating costs to federal awards, and that the supporting documentation and related reconciliations be retained, in accordance with the Uniform Guidance. The CAP should be reviewed periodically and updated for changes in operations as deemed necessary, and approved by the Board of Directors. Management’s Response/View of Responsible Officials Management agrees with this finding, see the Corrective Action Plan.

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 400330 2023-001
    Material Weakness
  • 400331 2023-002
    Significant Deficiency
  • 400332 2023-003
    Material Weakness
  • 400333 2023-004
    Material Weakness
  • 400334 2023-001
    Material Weakness
  • 400335 2023-002
    Significant Deficiency
  • 400336 2023-003
    Material Weakness
  • 400337 2023-004
    Material Weakness
  • 400338 2023-001
    Material Weakness
  • 400339 2023-002
    Significant Deficiency
  • 400340 2023-003
    Material Weakness
  • 400341 2023-004
    Material Weakness
  • 400342 2023-001
    Material Weakness
  • 400343 2023-002
    Significant Deficiency
  • 400344 2023-003
    Material Weakness
  • 400345 2023-004
    Material Weakness
  • 400346 2023-001
    Material Weakness
  • 400347 2023-002
    Significant Deficiency
  • 400348 2023-003
    Material Weakness
  • 400349 2023-004
    Material Weakness
  • 400350 2023-001
    Material Weakness
  • 400351 2023-002
    Significant Deficiency
  • 400352 2023-003
    Material Weakness
  • 400353 2023-004
    Material Weakness
  • 400354 2023-001
    Material Weakness
  • 400355 2023-002
    Significant Deficiency
  • 400356 2023-003
    Material Weakness
  • 400357 2023-004
    Material Weakness
  • 400358 2023-001
    Material Weakness
  • 400359 2023-002
    Significant Deficiency
  • 400360 2023-003
    Material Weakness
  • 400361 2023-004
    Material Weakness
  • 400362 2023-001
    Material Weakness
  • 400363 2023-002
    Significant Deficiency
  • 400365 2023-004
    Material Weakness
  • 400366 2023-001
    Material Weakness
  • 400367 2023-002
    Significant Deficiency
  • 400368 2023-003
    Material Weakness
  • 400369 2023-004
    Material Weakness
  • 400370 2023-001
    Material Weakness
  • 400371 2023-002
    Significant Deficiency
  • 400372 2023-003
    Material Weakness
  • 400373 2023-004
    Material Weakness
  • 976772 2023-001
    Material Weakness
  • 976773 2023-002
    Significant Deficiency
  • 976774 2023-003
    Material Weakness
  • 976775 2023-004
    Material Weakness
  • 976776 2023-001
    Material Weakness
  • 976777 2023-002
    Significant Deficiency
  • 976778 2023-003
    Material Weakness
  • 976779 2023-004
    Material Weakness
  • 976780 2023-001
    Material Weakness
  • 976781 2023-002
    Significant Deficiency
  • 976782 2023-003
    Material Weakness
  • 976783 2023-004
    Material Weakness
  • 976784 2023-001
    Material Weakness
  • 976785 2023-002
    Significant Deficiency
  • 976786 2023-003
    Material Weakness
  • 976787 2023-004
    Material Weakness
  • 976788 2023-001
    Material Weakness
  • 976789 2023-002
    Significant Deficiency
  • 976790 2023-003
    Material Weakness
  • 976791 2023-004
    Material Weakness
  • 976792 2023-001
    Material Weakness
  • 976793 2023-002
    Significant Deficiency
  • 976794 2023-003
    Material Weakness
  • 976795 2023-004
    Material Weakness
  • 976796 2023-001
    Material Weakness
  • 976797 2023-002
    Significant Deficiency
  • 976798 2023-003
    Material Weakness
  • 976799 2023-004
    Material Weakness
  • 976800 2023-001
    Material Weakness
  • 976801 2023-002
    Significant Deficiency
  • 976802 2023-003
    Material Weakness
  • 976803 2023-004
    Material Weakness
  • 976804 2023-001
    Material Weakness
  • 976805 2023-002
    Significant Deficiency
  • 976806 2023-003
    Material Weakness
  • 976807 2023-004
    Material Weakness
  • 976808 2023-001
    Material Weakness
  • 976809 2023-002
    Significant Deficiency
  • 976810 2023-003
    Material Weakness
  • 976811 2023-004
    Material Weakness
  • 976812 2023-001
    Material Weakness
  • 976813 2023-002
    Significant Deficiency
  • 976814 2023-003
    Material Weakness
  • 976815 2023-004
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $6.58M
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $453,161
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $359,298
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $76,708
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $67,178
10.557 Special Supplemental Nutrition Program for Women, Infants, and Children $56,015